Home › Kanser sa Esophagus › Tennessee › Nashville

Pag-aaral pangklinika para sa Kanser sa Esophagus sa Nashville, TN

19 pag-aaral para sa Kanser sa Esophagus ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Nashville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute, Nashville
Tennessee Oncology PLLC, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute - Pharmacy, Nashville
SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute- Pharmacy, Nashville
SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07519655

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral

Research Site, Nashville

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institue, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon - Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Nagre-recruitPhase 3

Research Site, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

US Oncology Research LLC, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Nagre-recruitObservasyonal na pag-aaral

Veterans Affairs Medical Center - Nashville, Nashville
Vanderbilt-Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT00899626

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Vanderbilt-Ingram Cancer Center, Nashville

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute (SCRI), Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT07181473

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Esophagus sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.